Our study days are sponsored by pharmaceutical companies, who provide funding that allows us to offer all events completely free of charge. Sponsors have no involvement in agenda development, speaker selection, or clinical content – this is managed entirely by MORPh’s clinical team.
The “Reducing cardiovascular risks in the diabetic patient: moving beyond HbA1c: PART 2 – Making the most of HF Consultations & Type 2 Diabetes: 2026 Guideline Updates” Webinar is free to access both live and on-demand for attendees. To watch on-demand without attending the webinar you can join the Associate Programmme.
This event will start at 18:30pm with the Welcome and Introductions. The webinar will begin shortly after. Our expert speakers will be discussing the following topics:
How to make the most of your HF Consultations
- What is Heart Failure
- Classification of Heart Failure
- Signs and Symptoms of Heart Failure/Breathlessness
- Pharmacotherapy of Chronic Heart Failure
Type 2 Diabetes: 2026 Guideline Updates – CPD Accredited
By the end of this session, participants will be able to:
- Understand the latest 2026 guidelines to support evidence-based clinical decision making in type 2 diabetes
- Apply guideline recommendations to select and sequence therapies tailored to individual patient needs in primary care
- Feel confident initiating and optimising medication, including safe titration and intensification in routine practice
- Interpret key monitoring parameters (e.g. HbA1c, renal function) during follow-up and recognise expected vs. suboptimal responses
- Manage common clinical challenges, including adverse effects, comorbidities, and when to escalate treatment or refer to specialist care